JP2003533675A5 - - Google Patents

Download PDF

Info

Publication number
JP2003533675A5
JP2003533675A5 JP2001570101A JP2001570101A JP2003533675A5 JP 2003533675 A5 JP2003533675 A5 JP 2003533675A5 JP 2001570101 A JP2001570101 A JP 2001570101A JP 2001570101 A JP2001570101 A JP 2001570101A JP 2003533675 A5 JP2003533675 A5 JP 2003533675A5
Authority
JP
Japan
Prior art keywords
analog
cells
pdgf
human animal
transgenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001570101A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003533675A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/009855 external-priority patent/WO2001072132A1/en
Publication of JP2003533675A publication Critical patent/JP2003533675A/ja
Publication of JP2003533675A5 publication Critical patent/JP2003533675A5/ja
Pending legal-status Critical Current

Links

JP2001570101A 2000-03-28 2001-03-28 血小板由来成長因子ｃ（ｐｄｇｆ−ｃ）を発現する非ヒトトランスジェニック動物およびそれらの使用 Pending JP2003533675A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19250700P 2000-03-28 2000-03-28
US60/192,507 2000-03-28
PCT/US2001/009855 WO2001072132A1 (en) 2000-03-28 2001-03-28 Non-human transgenic animals expressing platelet-derived growth factor c (pdgf-c) and uses thereof

Publications (2)

Publication Number Publication Date
JP2003533675A JP2003533675A (ja) 2003-11-11
JP2003533675A5 true JP2003533675A5 (enExample) 2007-04-05

Family

ID=22709954

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001570101A Pending JP2003533675A (ja) 2000-03-28 2001-03-28 血小板由来成長因子ｃ（ｐｄｇｆ−ｃ）を発現する非ヒトトランスジェニック動物およびそれらの使用

Country Status (7)

Country Link
US (1) US7034200B2 (enExample)
EP (1) EP1267627A1 (enExample)
JP (1) JP2003533675A (enExample)
CN (1) CN1419413A (enExample)
AU (1) AU2001249525A1 (enExample)
CA (1) CA2403829A1 (enExample)
WO (1) WO2001072132A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6663870B2 (en) * 1998-12-07 2003-12-16 Zymogenetics, Inc. Methods for promoting growth of bone using zvegf3
US20030046716A1 (en) * 2000-06-19 2003-03-06 Yann Echelard Transgenically produced platelet derived growth factor
AU2004209668A1 (en) * 2003-02-04 2004-08-19 Flanders Interuniversity Institute For Biotechnology VEGF-B and PDGF modulation of stem cells
CN104321343A (zh) * 2012-04-24 2015-01-28 斯鲁姆博詹尼克斯公司 抗pdgf-c抗体
CA3029332A1 (en) * 2016-07-01 2018-01-04 Ludwig Institute For Cancer Research Ltd Methods and compositions for pdgf-cc inhibition
KR102757711B1 (ko) * 2021-10-26 2025-01-21 고려대학교 산학협력단 Pdgf 유래 신규 펩타이드 및 이의 용도
CN114109328B (zh) * 2021-11-26 2023-06-16 西南石油大学 启停式双极可调恒流堵塞器

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5434132A (en) * 1988-03-21 1995-07-18 Imperial Cancer Research Technology, Ltd. Neuropeptide antagonists
US5789655A (en) * 1994-05-13 1998-08-04 The Regents Of The University Of California Transgenic animals expressing artificial epitope-tagged proteins
US6359194B1 (en) * 1995-02-10 2002-03-19 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease
DE19632532A1 (de) * 1996-08-13 1998-02-19 Boehringer Ingelheim Int Verfahren zur Herstellung von Säugetieren mit definierten genetischen Eigenschaften
WO1999047677A2 (en) * 1998-03-17 1999-09-23 Genentech, Inc. Polypeptides homologous to vegf and bmp1
US6432673B1 (en) * 1998-12-07 2002-08-13 Zymogenetics, Inc. Growth factor homolog ZVEGF3

Similar Documents

Publication Publication Date Title
JP2002519061A5 (enExample)
JP2003526716A5 (enExample)
JP2002524024A5 (enExample)
WO2003093296A3 (en) Kinase anchor protein muteins, peptides thereof, and related methods
JP2004538039A5 (enExample)
JP2002535332A5 (enExample)
JP2006516098A5 (enExample)
WO2002094009A3 (en) Methods for selecting and producing animals having a predicted level of immune response
EP3760234A3 (en) Rna interference for the treatment of gain-of-function disorders
EP2090657A3 (en) Anti-IL-12 antibodies, compositions, methods and uses
WO2002085926A3 (de) Verfahren zur herstellung stabiler, regenerierbarer antikörper-arrays
JP2004504479A5 (enExample)
AU6282700A (en) Transgenic mice and overexpression model of the gene ntrk3 (trkc) based thereon for the study and monitoring of treatments of anxiety, depression and related psychiatric diseases
JP2003533675A5 (enExample)
JP2003160581A5 (enExample)
NO20040158L (no) Fremgangsmåte til å amplifisere et Chordopoxvirus.
ITTO990992A0 (it) Metodo per produrre valvole a sfera.
DE60217797D1 (de) Spielsystem, Spielkontrollverfahren und entsprechendes Aufzeichungsmedium
WO2004057443A3 (en) Optimizing authentication service availability and responsiveness via client-side routing
MXPA03003170A (es) Metodo para el control termico de plagas.
JP2006508646A5 (enExample)
AU2002354531A1 (en) Expression cassettes for the transgenic expression of nucleic acids
JP2004516020A5 (enExample)
ATE493498T1 (de) Veränderung des pflanzen genoms durch induzierbaren, ortspezifischen rekombination von transgenen
JP2003531587A5 (enExample)